Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl R Clauser

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Molecular & Cellular Proteomics : MCP|May 1, 2017
Methods, Tools and Current Perspectives in ProteogenomicsKelly V Ruggles, Karsten Krug, Xiaojing Wang, et al.
Nature Communications|April 21, 2021
Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cellsChenxi Tian, Ying Huang, Karl R Clauser, et al.
Molecular & Cellular Proteomics : MCP|June 19, 2021
MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future ImmunotherapiesHannah B Taylor, Susan Klaeger, Karl R Clauser, et al.
Molecular & Cellular Proteomics : MCP|April 11, 2019
TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling ApproachJana Zecha, Shankha Satpathy, Tamara Kanashova, et al.
Nature Reviews. Cancer|March 3, 2022
Cancer proteogenomics: current impact and future prospectsD R Mani, Karsten Krug, Bing Zhang, et al.
Nature Communications|October 29, 2017
Site-specific identification and quantitation of endogenous SUMO modifications under native conditionsRyan J Lumpkin, Hongbo Gu, Yiying Zhu, et al.
Nature Methods|May 27, 2021
PANOPLY: a cloud-based platform for automated and reproducible proteogenomic data analysisD R Mani, Myranda Maynard, Ramani Kothadia, et al.
The EMBO Journal|April 21, 2007
Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrateDrew M Lowery, Karl R Clauser, Majbrit Hjerrild, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2019
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cellsChenxi Tian, Karl R Clauser, Daniel Öhlund, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
What can Ribo-seq and proteomics tell us about the non-canonical proteome?John R Prensner, Jennifer G Abelin, Leron W Kok, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Molecular & Cellular Proteomics : MCP|May 1, 2017
Methods, Tools and Current Perspectives in ProteogenomicsKelly V Ruggles, Karsten Krug, Xiaojing Wang, et al.
Nature Communications|April 21, 2021
Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cellsChenxi Tian, Ying Huang, Karl R Clauser, et al.
Molecular & Cellular Proteomics : MCP|June 19, 2021
MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future ImmunotherapiesHannah B Taylor, Susan Klaeger, Karl R Clauser, et al.
Molecular & Cellular Proteomics : MCP|April 11, 2019
TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling ApproachJana Zecha, Shankha Satpathy, Tamara Kanashova, et al.
Nature Reviews. Cancer|March 3, 2022
Cancer proteogenomics: current impact and future prospectsD R Mani, Karsten Krug, Bing Zhang, et al.
Nature Communications|October 29, 2017
Site-specific identification and quantitation of endogenous SUMO modifications under native conditionsRyan J Lumpkin, Hongbo Gu, Yiying Zhu, et al.
Nature Methods|May 27, 2021
PANOPLY: a cloud-based platform for automated and reproducible proteogenomic data analysisD R Mani, Myranda Maynard, Ramani Kothadia, et al.
The EMBO Journal|April 21, 2007
Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrateDrew M Lowery, Karl R Clauser, Majbrit Hjerrild, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2019
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cellsChenxi Tian, Karl R Clauser, Daniel Öhlund, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
What can Ribo-seq and proteomics tell us about the non-canonical proteome?John R Prensner, Jennifer G Abelin, Leron W Kok, et al.
Pageof 10